Doxorubicin augments rAAV-2 transduction in rat neuronal cells

Neurochemistry International

Volumn 55, Issue 7, 2009, Pages 521-528

  Zhang, Ting ^a   Hu, Jing ^a   Ding, Wei ^b   Wang, Xiaomin ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Doxorubicin; Gene therapy; Neuron; rAAV 2

Indexed keywords

DOXORUBICIN; ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; INTRACELLULAR TRANSPORT; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS VIRULENCE;

ANIMALS; CAPSID PROTEINS; COLORING AGENTS; DEPENDOVIRUS; DOXORUBICIN; FLUORESCENT DYES; IN SITU NICK-END LABELING; INDICATORS AND REAGENTS; LUCIFERASES; MICROSCOPY, CONFOCAL; NEOSTRIATUM; NEURONS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCELLULAR FRACTIONS; TETRAZOLIUM SALTS; THIAZOLES; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 69349096416     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.05.005     Document Type: Article

References (34)

1. Dewil M., Van Den Bosch L., and Robberecht W. Microglia in amyotrophic lateral sclerosis. Acta Neurol. Belg. 107 (2007) 63-70
2. Ding W., Yan Z., Zak R., Saavedra M., Rodman D.M., and Engelhardt J.F. Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol. 77 (2003) 7361-7366
3. Ding W., Zhang L., Yan Z., and Engelhardt J.F. Intracellular trafficking of adeno-associated viral vectors. Gene Ther. 12 (2005) 873-880
4. Ding W., Zhang L.N., Yeaman C., and Engelhardt J.F. rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion. Mol. Ther. 13 (2006) 671-682
5. Doroudchi M.M., Liauw J., Heaton K., Zhen Z., and Forsayeth J.R. Adeno-associated virus-mediated gene transfer of human aromatic l-amino acid decarboxylase protects mixed striatal primary cultures from l-DOPA toxicity. J. Neurochem. 93 (2005) 634-640
6. Gao G., Vandenberghe L.H., and Wilson J.M. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5 (2005) 285-297
7. Griffiths M., Neal J.W., and Gasque P. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. Int. Rev. Neurobiol. 82 (2007) 29-55
8. Inagaki K., Ma C., Storm T.A., Kay M.A., and Nakai H. The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice. J. Virol. 81 (2007) 11304-11321
9. Jang Y.M., Kendaiah S., Drew B., Phillips T., Selman C., Julian D., and Leeuwenburgh C. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 577 (2004) 483-490
10. Jia S.Q., Zhang F.L., and Ding W. Type 2 adeno-assocaited virus labeled with Alexa Fluor 647 maintained its native infectivity. Chinese J. Biochem. Mol. Biol. 24 (2008) 1152-1157
11. Johnson J.S., and Samulski R.J. Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J. Virol. 83 (2009) 2632-2644
12. Kaplitt M.G., Feigin A., Tang C., Fitzsimons H.L., Mattis P., Lawlor P.A., Bland R.J., Young D., Strybing K., Eidelberg D., and During M.J. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369 (2007) 2097-2105
13. Kay M.A. AAV vectors and tumorigenicity. Nat. Biotechnol. 25 (2007) 1111-1113
14. Klein R.L., Meyer E.M., Peel A.L., Zolotukhin S., Meyers C., Muzyczka N., and King M.A. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp. Neurol. 150 (1998) 183-194
15. Maini C.L., Sciuto R., Ferraironi A., Vici P., Tofani A., Festa A., Conti F., and Lopez M. Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity. J. Nucl. Cardiol. 4 (1997) 502-508
16. Mandel R.J., Manfredsson F.P., Foust K.D., Rising A., Reimsnider S., Nash K., and Burger C. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol. Ther. 13 (2006) 463-483
17. Manno C.S., Pierce G.F., Arruda V.R., Glader B., Ragni M., Rasko J.J., Ozelo M.C., Hoots K., Blatt P., Konkle B., Dake M., Kaye R., Razavi M., Zajko A., Zehnder J., Rustagi P.K., Nakai H., Chew A., Leonard D., Wright J.F., Lessard R.R., Sommer J.M., Tigges M., Sabatino D., Luk A., Jiang H., Mingozzi F., Couto L., Ertl H.C., High K.A., and Kay M.A. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12 (2006) 342-347
18. McCown T.J., Xiao X., Li J., Breese G.R., and Samulski R.J. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713 (1996) 99-107
19. Migrino R.Q., Aggarwal D., Konorev E., Brahmbhatt T., Bright M., and Kalyanaraman B. Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med. Biol. 34 (2008) 208-214
20. Natkunarajah M., Trittibach P., McIntosh J., Duran Y., Barker S.E., Smith A.J., Nathwani A.C., and Ali R.R. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. Gene Ther. 15 (2008) 463-467
21. Qing K., Mah C., Hansen J., Zhou S., Dwarki V., and Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5 (1999) 71-77
22. Raina A.K., Pardo P., Rottkamp C.A., Zhu X., Pereira-Smith O.M., and Smith M.A. Neurons in Alzheimer disease emerge from senescence. Mech. Ageing Dev. 123 (2001) 3-9
23. Ren C., White A.F., and Ponnazhagan S. Notch1 augments intracellular trafficking of adeno-associated virus type 2. J. Virol. 81 (2007) 2069-2073
24. Shevtsova Z., Malik J.M., Michel U., Bahr M., and Kugler S. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp. Physiol. 90 (2005) 53-59
25. Soloman R., and Gabizon A.A. Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin. Clin. Lymphoma Myeloma 8 (2008) 21-32
26. Somia N., and Verma I.M. Gene therapy: trials and tribulations. Nat. Rev. Genet. 1 (2000) 91-99
27. Summerford C., Bartlett J.S., and Samulski R.J. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5 (1999) 78-82
28. Summerford C., and Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72 (1998) 1438-1445
29. Tenenbaum L., Chtarto A., Lehtonen E., Velu T., Brotchi J., and Levivier M. Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 6 Suppl. 1 (2004) S212-S222
30. Van Vliet K.M., Blouin V., Brument N., Agbandje-McKenna M., and Snyder R.O. The role of the adeno-associated virus capsid in gene transfer. Methods Mol. Biol. 437 (2008) 51-91
31. Weger S., Hammer E., Gotz A., and Heilbronn R. Identification of a cytoplasmic interaction partner of the large regulatory proteins Rep78/Rep68 of adeno-associated virus type 2 (AAV-2). Virology 362 (2007) 192-206
32. Yan Z., Zak R., Luxton G.W., Ritchie T.C., Bantel-Schaal U., and Engelhardt J.F. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76 (2002) 2043-2053
33. Yan Z., Zak R., Zhang Y., Ding W., Godwin S., Munson K., Peluso R., and Engelhardt J.F. Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J. Virol. 78 (2004) 2863-2874
34. Yokoi K., Kachi S., Zhang H.S., Gregory P.D., Spratt S.K., Samulski R.J., and Campochiaro P.A. Ocular gene transfer with self-complementary AAV vectors. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3324-3328